Clinical Trial Update: Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase 3 multicenter randomized trial evaluating pantoprazole with and without domperidone for gastroesophageal reflux disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Domperidone (domperidone)
• Pantoprazole (pantoprazole)
• Pantoprazole + Domperidone (pantoprazole domperidone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: WITHDRAWN